| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 51.027.028 | 52.620.854 | 61.049.551 | 74.355.642 | 91.340.119 | 95.612.447 | 106.155.230 | 131.192.451 | 156.054.500 | 179.784.327 |
| Total Income - EUR | 51.145.115 | 52.684.212 | 61.145.888 | 74.454.971 | 91.985.547 | 98.137.122 | 107.923.159 | 133.247.087 | 158.064.998 | 182.495.440 |
| Total Expenses - EUR | 49.642.858 | 51.136.371 | 59.201.207 | 72.233.864 | 88.364.161 | 93.215.554 | 101.055.809 | 125.700.124 | 148.240.309 | 170.590.833 |
| Gross Profit/Loss - EUR | 1.502.258 | 1.547.841 | 1.944.681 | 2.221.108 | 3.621.386 | 4.921.569 | 6.867.350 | 7.546.963 | 9.824.689 | 11.904.606 |
| Net Profit/Loss - EUR | 1.280.394 | 1.329.840 | 1.663.393 | 1.874.181 | 3.150.467 | 4.380.382 | 6.005.589 | 6.577.828 | 8.511.647 | 10.480.477 |
| Employees | 389 | 424 | 468 | 497 | 543 | 560 | 592 | 602 | 645 | 641 |
Check the financial reports for the company - Farmaceutica Argesfarm Sa
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.229.047 | 9.854.212 | 12.117.560 | 13.863.668 | 14.635.244 | 15.202.018 | 16.531.432 | 17.283.204 | 17.514.217 | 17.542.339 |
| Current Assets | 10.730.341 | 14.021.555 | 17.553.290 | 26.653.660 | 29.676.316 | 31.225.495 | 33.809.064 | 45.290.105 | 54.444.730 | 53.269.119 |
| Inventories | 3.956.331 | 5.386.637 | 6.267.432 | 7.180.567 | 8.570.176 | 10.852.530 | 12.279.225 | 14.507.843 | 18.996.828 | 17.757.163 |
| Receivables | 6.333.510 | 5.057.188 | 10.223.535 | 18.121.612 | 20.333.694 | 19.489.488 | 20.571.993 | 29.331.636 | 31.778.919 | 33.824.840 |
| Cash | 440.500 | 3.577.730 | 1.062.323 | 1.351.481 | 772.446 | 883.477 | 957.846 | 1.450.626 | 3.668.984 | 1.687.116 |
| Shareholders Funds | 13.710.935 | 14.900.943 | 16.665.318 | 18.669.441 | 19.732.614 | 20.648.170 | 22.289.616 | 22.912.376 | 24.796.661 | 27.115.198 |
| Social Capital | 2.303.688 | 2.280.194 | 2.241.609 | 2.200.471 | 2.157.857 | 2.116.949 | 2.070.004 | 2.076.426 | 2.070.129 | 2.058.560 |
| Debts | 5.370.444 | 9.015.787 | 13.062.390 | 21.831.890 | 24.547.238 | 25.786.646 | 28.092.510 | 39.615.524 | 46.947.027 | 43.525.909 |
| Income in Advance | 1.215 | 1.208 | 1.215 | 1.198 | 3.120 | 2.718 | 3.101 | 3.099 | 5.629 | 5.803 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmaceutica Argesfarm Sa